Cargando…
Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice
Ischemic stroke is the leading cause of globe death and permanent disability, but its therapeutic strategies are limited. Over the past decades, multiprotein complexes called inflammasomes have been shown as promising targets in ischemic stroke. Here, we examined vinpocetine (Vinp), a synthetic drug...
Autores principales: | Han, Dong, Wang, Jue, Wen, Lulu, Sun, Miao, Liu, Hang, Gao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853762/ https://www.ncbi.nlm.nih.gov/pubmed/33351536 http://dx.doi.org/10.1097/FJC.0000000000000945 |
Ejemplares similares
-
Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020) -
Remote Limb Ischemic Postconditioning Protects against Ischemic Stroke via Modulating Microglia/Macrophage Polarization in Mice
por: Han, Dong, et al.
Publicado: (2021) -
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
por: Feng, Ya-Shuo, et al.
Publicado: (2020) -
Genistein Attenuates Acute Cerebral Ischemic Damage by Inhibiting the NLRP3 Inflammasome in Reproductively Senescent Mice
por: Wang, Shiquan, et al.
Publicado: (2020) -
Anti-Inflammatory Effects of Vinpocetine in Atherosclerosis and Ischemic Stroke: A Review of the Literature
por: Zhang, Linjie, et al.
Publicado: (2014)